FAM72C
gene geneOn this page
Also known as RP5-998N21.9
Summary
FAM72C (family with sequence similarity 72 member C, HGNC:30602) is a protein-coding gene on chromosome 1q21.1, encoding Protein FAM72C (H0Y354).
Located in cytosol and intracellular membrane-bounded organelle.
Source: NCBI Gene 554282 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 11 total
- MANE Select transcript:
NM_001287385
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30602 |
| Approved symbol | FAM72C |
| Name | family with sequence similarity 72 member C |
| Location | 1q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RP5-998N21.9 |
| Ensembl gene | ENSG00000263513 |
| Ensembl biotype | protein_coding |
| OMIM | 616853 |
| Entrez | 554282 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000369175, ENST00000584486, ENST00000931575, ENST00000931576
RefSeq mRNA: 3 — MANE Select: NM_001287385
NM_001287385, NM_001346070, NM_001346071
CCDS: CCDS72850, CCDS86008
Canonical transcript exons
ENST00000584486 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001641767 | 143955287 | 143956481 |
| ENSE00003472164 | 143964855 | 143964979 |
| ENSE00003600104 | 143968924 | 143969001 |
| ENSE00003918733 | 143970990 | 143971986 |
Expression profiles
Bgee: expression breadth ubiquitous, 115 present calls, max score 85.86.
FANTOM5 (CAGE): breadth broad, TPM avg 1.5495 / max 37.3756, expressed in 680 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201666 | 1.5495 | 680 |
| 201665 | 0.4669 | 302 |
Top tissues by expression
118 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.86 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.61 | gold quality |
| lymph node | UBERON:0000029 | 70.55 | gold quality |
| ventricular zone | UBERON:0003053 | 70.03 | gold quality |
| ganglionic eminence | UBERON:0004023 | 67.30 | gold quality |
| stromal cell of endometrium | CL:0002255 | 64.61 | gold quality |
| vermiform appendix | UBERON:0001154 | 63.08 | gold quality |
| endometrium | UBERON:0001295 | 61.96 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 61.63 | gold quality |
| bone marrow | UBERON:0002371 | 60.56 | gold quality |
| esophagus mucosa | UBERON:0002469 | 59.98 | gold quality |
| adrenal tissue | UBERON:0018303 | 58.65 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 58.07 | gold quality |
| cerebellar cortex | UBERON:0002129 | 57.63 | gold quality |
| rectum | UBERON:0001052 | 57.55 | gold quality |
| cerebellum | UBERON:0002037 | 57.49 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 57.40 | gold quality |
| duodenum | UBERON:0002114 | 56.43 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 56.01 | gold quality |
| monocyte | CL:0000576 | 55.47 | gold quality |
| spleen | UBERON:0002106 | 55.44 | gold quality |
| granulocyte | CL:0000094 | 55.42 | gold quality |
| leukocyte | CL:0000738 | 55.06 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 54.24 | gold quality |
| skin of leg | UBERON:0001511 | 54.00 | gold quality |
| tonsil | UBERON:0002372 | 53.88 | gold quality |
| zone of skin | UBERON:0000014 | 53.78 | gold quality |
| skin of abdomen | UBERON:0001416 | 53.60 | gold quality |
| placenta | UBERON:0001987 | 52.81 | gold quality |
| bone marrow cell | CL:0002092 | 52.64 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.77 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
61 targeting FAM72C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
Literature-anchored findings (GeneRIF, showing 1)
- An epistemological characterization of the human tumorigenic neuronal paralogous FAM72 gene loci (FAM72A, FAM72B, FAM72C, FAM72D). (PMID:26206078)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | FAM72A | ENSDARG00000070621 |
| mus_musculus | Fam72a | ENSMUSG00000055184 |
| rattus_norvegicus | Fam72a | ENSRNOG00000042747 |
Paralogs (3): FAM72B (ENSG00000188610), FAM72A (ENSG00000196550), FAM72D (ENSG00000215784)
Protein
Protein identifiers
Protein FAM72C — H0Y354 (reviewed: H0Y354)
All UniProt accessions (2): A0A087WSW5, H0Y354
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM72 family.
RefSeq proteins (3): NP_001274314, NP_001332999, NP_001333000 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026768 | YPEH2ZP | Family |
Pfam: PF14976
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-H0Y354-F1 | 85.51 | 0.66 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 37 (showing top):
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP, DODD_NASOPHARYNGEAL_CARCINOMA_UP, chr1q21, VECCHI_GASTRIC_CANCER_EARLY_UP, CHICAS_RB1_TARGETS_GROWING, JOHNSTONE_PARVB_TARGETS_3_DN, ZWANG_DOWN_BY_2ND_EGF_PULSE, MIR1277_5P, MIR3121_3P, MIR10527_5P, MIR4482_3P, MIR206, MIR1_3P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): cytosol (GO:0005829)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
520 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM72C | SRGAP2B | P0DMP2 | 590 |
| FAM72C | SRGAP2C | P0DJJ0 | 518 |
| FAM72C | ANKRD20A3P | Q5VUR7 | 518 |
| FAM72C | ARHGAP11B | Q3KRB8 | 514 |
| FAM72C | ZNG1F | Q4V339 | 491 |
| FAM72C | ZNG1C | Q5JTY5 | 490 |
| FAM72C | GTF2H2C | Q6P1K8 | 456 |
| FAM72C | ARHGEF35 | A5YM69 | 452 |
| FAM72C | ZNG1A | Q9BRT8 | 448 |
| FAM72C | ANKRD20A4P | Q4UJ75 | 447 |
| FAM72C | ANKRD20A2P | Q5SQ80 | 447 |
| FAM72C | GTF2H2 | Q13888 | 436 |
| FAM72C | OTUD7A | Q8TE49 | 432 |
| FAM72C | CD8B2 | A6NJW9 | 429 |
| FAM72C | ALG1L2 | C9J202 | 420 |
IntAct
0 interactions, top by confidence:
BioGRID (2): FAM72C (Negative Genetic), FAM72C (Negative Genetic)
ESM2 similar proteins: A1KXW8, A6QL50, E1BGQ2, H0Y354, O94955, P47224, Q08326, Q0IIH8, Q1JQA1, Q1RMS8, Q1RMZ1, Q2TBU5, Q3T1H6, Q4R372, Q4R528, Q4R9C4, Q5F480, Q5F4A1, Q5I0G3, Q5RCQ0, Q5RFG8, Q5TFE4, Q5TYM5, Q641X7, Q6L9T8, Q6PIP5, Q7L622, Q7Z6J8, Q7ZX59, Q86X60, Q8BFZ8, Q8BKW4, Q8BM85, Q8BX13, Q8CEL2, Q8N5C7, Q8N635, Q8NHU2, Q8TCF1, Q8TCJ0
Diamond homologs: A1KXW8, A6QL50, H0Y354, Q5TYM5, Q6L9T8, Q86X60, Q8BFZ8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
11 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 8 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1678 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:143964978:GT:G | acceptor_gain | 1.0000 |
| 1:143971812:G:T | donor_gain | 1.0000 |
| 1:143971814:C:A | donor_gain | 1.0000 |
| 1:143971841:AGTCC:A | donor_gain | 1.0000 |
| 1:143971843:G:T | donor_gain | 1.0000 |
| 1:143971845:C:A | donor_gain | 1.0000 |
| 1:143971857:G:GT | donor_gain | 1.0000 |
| 1:143971858:T:TA | donor_gain | 1.0000 |
| 1:143956478:ACACC:A | acceptor_loss | 0.9900 |
| 1:143956479:CAC:C | acceptor_gain | 0.9900 |
| 1:143956479:CACCT:C | acceptor_loss | 0.9900 |
| 1:143956480:ACCTG:A | acceptor_loss | 0.9900 |
| 1:143956481:CCT:C | acceptor_loss | 0.9900 |
| 1:143956482:C:CA | acceptor_loss | 0.9900 |
| 1:143956482:C:CC | acceptor_gain | 0.9900 |
| 1:143956483:T:A | acceptor_loss | 0.9900 |
| 1:143964849:TCTTA:T | donor_loss | 0.9900 |
| 1:143964850:CTTAC:C | donor_loss | 0.9900 |
| 1:143964851:TTACC:T | donor_loss | 0.9900 |
| 1:143964852:TA:T | donor_loss | 0.9900 |
| 1:143964853:A:AG | donor_loss | 0.9900 |
| 1:143964978:G:GG | acceptor_gain | 0.9900 |
| 1:143964978:GTG:G | acceptor_gain | 0.9900 |
| 1:143964978:GTGG:G | acceptor_gain | 0.9900 |
| 1:143964979:A:AG | acceptor_gain | 0.9900 |
| 1:143964979:AGT:A | acceptor_gain | 0.9900 |
| 1:143964979:AGTG:A | acceptor_gain | 0.9900 |
| 1:143968997:CTGCG:C | acceptor_gain | 0.9900 |
| 1:143968998:TGCGC:T | acceptor_loss | 0.9900 |
| 1:143969000:CGCTG:C | acceptor_loss | 0.9900 |
AlphaMissense
997 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:143971082:G:C | F20L | 0.856 |
| 1:143971082:G:T | F20L | 0.856 |
| 1:143971084:A:G | F20L | 0.856 |
| 1:143971013:G:C | F43L | 0.779 |
| 1:143971013:G:T | F43L | 0.779 |
| 1:143971015:A:G | F43L | 0.779 |
| 1:143964898:A:C | F104L | 0.751 |
| 1:143964898:A:T | F104L | 0.751 |
| 1:143964900:A:G | F104L | 0.751 |
| 1:143971118:G:C | F8L | 0.694 |
| 1:143971118:G:T | F8L | 0.694 |
| 1:143971120:A:G | F8L | 0.694 |
| 1:143968989:G:C | F55L | 0.682 |
| 1:143968989:G:T | F55L | 0.682 |
| 1:143968991:A:G | F55L | 0.682 |
| 1:143971064:G:C | S26R | 0.660 |
| 1:143971064:G:T | S26R | 0.660 |
| 1:143971066:T:G | S26R | 0.660 |
| 1:143968971:G:C | F61L | 0.628 |
| 1:143968971:G:T | F61L | 0.628 |
| 1:143968973:A:G | F61L | 0.628 |
| 1:143964907:G:C | F101L | 0.603 |
| 1:143964907:G:T | F101L | 0.603 |
| 1:143964909:A:G | F101L | 0.603 |
dbSNP variants (sampled 300 via entrez): RS10718 (1:143955516 G>A), RS1156261188 (1:143969554 T>C), RS1156324725 (1:143967935 G>A), RS1156453836 (1:143971273 G>A), RS1156715574 (1:143966331 A>T), RS1156932126 (1:143967082 C>A), RS1157213736 (1:143959977 C>A), RS1157591847 (1:143974651 A>G), RS1157619331 (1:143957595 T>C), RS1157652923 (1:143959536 A>G), RS1157683199 (1:143958203 CTCG>C), RS1157770259 (1:143972982 C>A,T), RS1157815898 (1:143975048 A>G), RS1157962614 (1:143974273 C>A,T), RS1158358905 (1:143955642 G>T)
Disease associations
OMIM: gene MIM:616853 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| manganese chloride | increases expression, increases abundance | 1 |
| azoxystrobin | increases expression | 1 |
| fenpyroximate | increases expression | 1 |
| 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide | increases expression | 1 |
| pyrimidifen | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Antimycin A | increases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Rotenone | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.